|1.||Parle, Milind: 17 articles (03/2012 - 10/2003)|
|2.||Ryu, Jong Hoon: 11 articles (07/2015 - 08/2006)|
|3.||Kim, Young Choong: 9 articles (01/2013 - 01/2003)|
|4.||Lee, Ki Yong: 9 articles (11/2012 - 01/2003)|
|5.||Furey, Maura L: 8 articles (06/2015 - 10/2006)|
|6.||Nurten, Asiye: 8 articles (05/2015 - 09/2005)|
|7.||Blokland, Arjan: 7 articles (10/2015 - 12/2005)|
|8.||Drevets, Wayne C: 7 articles (06/2015 - 10/2006)|
|9.||Sung, Sang Hyun: 7 articles (01/2015 - 02/2005)|
|10.||Kim, Dong Hyun: 7 articles (07/2013 - 08/2006)|
|1.||Amnesia (Dissociative Amnesia)
01/01/1993 - "MSF was highly effective in reducing scopolamine-induced amnesia."
01/01/2015 - "The hydroalcoholic extract of Emilia coccinae (HEEC) at the dose of 200 mg/kg significantly improved the memory of rats and reversed the amnesia induced by scopolamine. "
12/01/2014 - "Our results confirmed that AE showed significant improvement in cognitive deficit in scopolamine-induced amnesia animal model. "
03/25/2013 - "In vivo efficacy tested in scopolamine induced amnesia model indicated significant improvement in cognitive function in mice group treated with developed nanocarrier based formulations as compared to the control group."
01/01/2012 - "Cyclo(L-Phe-L-Phe) also significantly improved accuracy rates in a radial maze test in rats and increased step-through latencies in a passive avoidance test in mice with scopolamine-induced amnesia. "
|2.||Motion Sickness (Airsickness)
08/01/2005 - "Scopolamine is highly effective for the treatment of seasickness. "
01/01/1996 - "A strong correlation was found between motion sickness and emetic sequelae after surgery, and patients with a history of motion sickness benefited most from hyoscine."
08/01/2005 - "Nevertheless, transdermal therapeutic system (TTS) scopolamine, despite high compliance on the part of persons treated by the drug, fails to provide protection against seasickness in 26-38% of patients. "
01/01/1987 - "We conclude that transdermal scopolamine's efficacy against seasickness during a 3-day cruise was not associated with significant side effects and, therefore, we find the drug suitable for long-term use by sailing crews."
01/01/1992 - "We conclude that buccal scopolamine is more effective than a placebo in treating ongoing motion sickness."
|3.||Memory Disorders (Memory Loss)
11/01/2013 - "EUE significantly improved the impairment of short-term or working memory induced by scopolamine in the Y-maze and significantly reversed learning and memory deficits in mice as measured by the passive avoidance and Morris water maze tests. "
01/01/2006 - "DM (40 mg/kg i.p.) was effective in reversing the reference memory deficit induced by administration of scopolamine. "
01/12/2015 - "While orally RA administration (16 and 32 mg/kg) improved learning and memory in control rats, it reversed learning and memory deficits of scopolamine received groups. "
04/10/2014 - "Swimming improved the emotional memory by itself and restored the emotional memory deficit induced by the intra-CA1 injection of scopolamine. "
08/01/2013 - "PEBT improved memory deficits during consolidation and retrieval induced by scopolamine. "
02/01/1989 - "The number of patients reporting "zero nausea" was significantly greater with scopolamine patches than with placebo patches (13 vs 1, P less than 0.01). "
10/01/2013 - "The primary aim of this study was to clarify the effect of sublingual scopolamine on the intensity of nausea. "
10/01/2013 - "When the patients had nausea, they were administered a solution of scopolamine at 0.15 mg sublingually. "
06/01/2013 - "To prevent the participants of parabolic flights from nausea they are optionally treated with subcutaneously injected antiemetic scopolamine. "
07/01/2010 - "The scopolamine patch provides a moderate reduction in the nausea associated with UAE but is associated with infrequent but notable episodes of patient disorientation."
|5.||Postoperative Nausea and Vomiting (PONV)
11/01/1991 - "Transderm scopolamine was effective in reducing but not eliminating postoperative nausea."
11/01/1991 - "A randomized prospective study of 201 patients in two institutions was performed to evaluate the efficacy of a transderm scopolamine patch in the control of postoperative nausea. "
01/01/2014 - "Clinical trials with transdermal scopolamine have consistently demonstrated its safety and efficacy in PONV. "
01/01/2008 - "Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial."
03/01/1996 - "In a prospective double-blind trial, transdermal scopolamine (TS) was compared to placebo (P) in the prevention of postoperative nausea and vomiting (PONV) within a 48-h interval. "
|2.||Acetylcholine (Acetylcholine Chloride)
|5.||Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
|7.||Histamine (Histamine Dihydrochloride)
|8.||Morphine (MS Contin)
|10.||Dizocilpine Maleate (Dizocilpine)
|3.||Gynecologic Surgical Procedures (Gynecologic Surgery)